Dendropanax morbiferus leaf extract facilitates oligodendrocyte development.

Area of Science:

• Neuroscience
• Pharmacology
• Cell Biology

Background:

• Multiple sclerosis (MS) treatment requires combined anti-inflammatory, neuroprotective, and regenerative strategies.
• Dendropanax morbiferus (DM) exhibits anti-inflammatory and anti-oxidative properties, suggesting potential benefits for MS.
• The effect of DM on myelination, a key regenerative process in MS, remains unexplored.

Purpose of the Study:

• To investigate the impact of Dendropanax morbiferus (DM) leaf ethanol extracts on oligodendrocyte (OL) differentiation and myelination.
• To determine if DM enhances the regenerative processes critical for multiple sclerosis treatment.

Main Methods:

• Primary cultures of mixed glia and pure oligodendrocyte precursor cells (OPCs) were treated with DM extracts.
• Oligodendrocyte differentiation and myelination were assessed using various assays, including membrane size analysis and gene expression profiling.
• Western blot analysis was performed to evaluate protein expression (MBP, p-ERK1/2).
• Myelinating co-cultures were used to assess axonal contacts and myelin gene upregulation (Myrf, CNP, PLP).
• Phytochemical analysis (LC-MS/MS) identified components within the DM extracts.

Main Results:

• DM extracts increased OL membrane size in both mixed glial and pure OPC cultures.
• Gene expression patterns related to OL lineage were altered by DM treatment.
• Western blot analysis revealed upregulation of Myelin Basic Protein (MBP) and phosphorylation of ERK1/2 in DM-treated OPCs.
• In myelinating co-cultures, DM enhanced OL differentiation, increased axonal contacts, and upregulated myelin genes (Myrf, CNP, PLP).
• LC-MS/MS identified bioactive compounds like quercetin and cannabidiol in DM extracts.

Conclusions:

• Dendropanax morbiferus extracts promote oligodendrocyte differentiation and enhance myelination by increasing membrane size and axonal contacts.
• The findings suggest DM's potential as a therapeutic agent for promoting myelin repair in conditions like multiple sclerosis.
• DM contains multiple bioactive components that warrant further investigation for their role in enhancing myelination.